Vaccination against infection in patients with multiple sclerosis

Area of Science:

• Neurology
• Immunology
• Vaccinology

Background:

• Bacterial and viral infections can trigger relapses and disease progression in multiple sclerosis (MS).
• Preventive vaccination is crucial for individuals with MS to mitigate risks from communicable diseases.
• Concerns regarding potential adverse effects of immunizations on MS course necessitate careful evaluation.

Purpose of the Study:

• To review the indications for and potential adverse effects of various vaccines in patients diagnosed with MS.
• To address the complexities of vaccination in the context of current immunomodulatory therapies used for MS management.

Main Methods:

• Literature review of studies investigating vaccine safety and efficacy in multiple sclerosis patients.
• Analysis of vaccine contraindications and risks specific to the MS population.
• Examination of the impact of immunosuppressive/immunomodulatory therapies on vaccine response in MS.

Main Results:

• Certain vaccines, like those for tetanus and hepatitis B, show no increased risk of MS exacerbation.
• Other vaccines, such as yellow fever, are contraindicated for individuals with MS.
• Immunomodulatory therapies in MS patients may affect susceptibility to infections and response to vaccination.

Conclusions:

• Vaccination decisions for MS patients require a risk-benefit assessment, considering individual disease status and therapy.
• Careful consideration of vaccine types and timing is essential, particularly for patients on immunosuppressive treatments.
• Further research is needed to optimize vaccination strategies for individuals with multiple sclerosis undergoing treatment.